Creo Medical has announced the signing of a non-exclusive licence and royalty agreement with a global surgical robotics company, CMR Surgical, providing further momentum to an already busy FY22. Under the terms of the agreement, CMR will be permitted to integrate certain features of Creo’s Kamaptive technology into its Versius surgical robotic system, a next-generation laparoscopic surgery robot. The details of the licence and royalty agreement remain undisclosed, but the deal represents another ....
25 Oct 2022
Creo Medical - Second robotics deal signed
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Creo Medical - Second robotics deal signed
Creo Medical Group Plc (CREO:LON) | 34.8 0 0.0% | Mkt Cap: 125.6m
- Published:
25 Oct 2022 -
Author:
Soo Romanoff -
Pages:
2
Creo Medical has announced the signing of a non-exclusive licence and royalty agreement with a global surgical robotics company, CMR Surgical, providing further momentum to an already busy FY22. Under the terms of the agreement, CMR will be permitted to integrate certain features of Creo’s Kamaptive technology into its Versius surgical robotic system, a next-generation laparoscopic surgery robot. The details of the licence and royalty agreement remain undisclosed, but the deal represents another ....